104 related articles for article (PubMed ID: 38714266)
1. Loss of cytidine deaminase expression as a potential attempt to counteract the process of carcinogenesis by reducing basal PARP-1 activity and increasing tau levels.
Amor-Guéret M
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167213. PubMed ID: 38714266
[TBL] [Abstract][Full Text] [Related]
2. Cytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumors.
Onclercq-Delic R; Buhagiar-Labarchède G; Leboucher S; Larcher T; Ledevin M; Machon C; Guitton J; Amor-Guéret M
Cancer Lett; 2023 Feb; 555():216030. PubMed ID: 36496104
[TBL] [Abstract][Full Text] [Related]
3. A decrease in NAMPT activity impairs basal PARP-1 activity in cytidine deaminase deficient-cells, independently of NAD
Silveira SC; Buhagiar-Labarchède G; Onclercq-Delic R; Gemble S; Bou Samra E; Mameri H; Duchambon P; Machon C; Guitton J; Amor-Guéret M
Sci Rep; 2020 Aug; 10(1):13907. PubMed ID: 32807821
[TBL] [Abstract][Full Text] [Related]
4. Pyrimidine Pool Disequilibrium Induced by a Cytidine Deaminase Deficiency Inhibits PARP-1 Activity, Leading to the Under Replication of DNA.
Gemble S; Ahuja A; Buhagiar-Labarchède G; Onclercq-Delic R; Dairou J; Biard DS; Lambert S; Lopes M; Amor-Guéret M
PLoS Genet; 2015 Jul; 11(7):e1005384. PubMed ID: 26181065
[TBL] [Abstract][Full Text] [Related]
5. Cytidine deaminase deficiency impairs sister chromatid disjunction by decreasing PARP-1 activity.
Gemble S; Buhagiar-Labarchède G; Onclercq-Delic R; Jaulin C; Amor-Guéret M
Cell Cycle; 2017 Jun; 16(11):1128-1135. PubMed ID: 28463527
[TBL] [Abstract][Full Text] [Related]
6. Contribution of Cytidine Deaminase to Thymidylate Biosynthesis in Trypanosoma brucei: Intracellular Localization and Properties of the Enzyme.
Moro-Bulnes A; Castillo-Acosta VM; Valente M; Carrero-Lérida J; Pérez-Moreno G; Ruiz-Pérez LM; González-Pacanowska D
mSphere; 2019 Aug; 4(4):. PubMed ID: 31391279
[TBL] [Abstract][Full Text] [Related]
7. A role for Tau protein in maintaining ribosomal DNA stability and cytidine deaminase-deficient cell survival.
Bou Samra E; Buhagiar-Labarchède G; Machon C; Guitton J; Onclercq-Delic R; Green MR; Alibert O; Gazin C; Veaute X; Amor-Guéret M
Nat Commun; 2017 Sep; 8(1):693. PubMed ID: 28947735
[TBL] [Abstract][Full Text] [Related]
8. A balanced pyrimidine pool is required for optimal Chk1 activation to prevent ultrafine anaphase bridge formation.
Gemble S; Buhagiar-Labarchède G; Onclercq-Delic R; Biard D; Lambert S; Amor-Guéret M
J Cell Sci; 2016 Aug; 129(16):3167-77. PubMed ID: 27383768
[TBL] [Abstract][Full Text] [Related]
9. Site directed mutagenesis as a tool to understand the catalytic mechanism of human cytidine deaminase.
Vincenzetti S; Pucciarelli S; Carpi FM; Micozzi D; Polzonetti V; Natalini P; Santarelli I; Polidori P; Vita A
Protein Pept Lett; 2013 May; 20(5):538-49. PubMed ID: 23033855
[TBL] [Abstract][Full Text] [Related]
10. Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels.
Mameri H; Buhagiar-Labarchède G; Fontaine G; Corcelle C; Barette C; Onclercq-Delic R; Beauvineau C; Mahuteau-Betzer F; Amor-Guéret M
Cell Mol Life Sci; 2022 Aug; 79(8):465. PubMed ID: 35925417
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of Cytidine Deaminase in Human Diseases: A New Opportunity for Therapy?
Frances A; Cordelier P
Mol Ther; 2020 Feb; 28(2):357-366. PubMed ID: 31870623
[TBL] [Abstract][Full Text] [Related]
12. Of the Nine Cytidine Deaminase-Like Genes in Arabidopsis, Eight Are Pseudogenes and Only One Is Required to Maintain Pyrimidine Homeostasis in Vivo.
Chen M; Herde M; Witte CP
Plant Physiol; 2016 Jun; 171(2):799-809. PubMed ID: 27208239
[TBL] [Abstract][Full Text] [Related]
13. Cytidine deaminase activity increases in the blood of breast cancer patients.
Buhagiar-Labarchède G; Onclercq-Delic R; Vacher S; Berger F; Bièche I; Stoppa-Lyonnet D; Amor-Guéret M
Sci Rep; 2022 Aug; 12(1):14062. PubMed ID: 35982128
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and structural analysis of the Klebsiella pneumoniae cytidine deaminase CDA.
Liu W; Shang F; Chen Y; Lan J; Wang L; Chen J; Gao P; Ha NC; Quan C; Nam KH; Xu Y
Biochem Biophys Res Commun; 2019 Nov; 519(2):280-286. PubMed ID: 31495495
[TBL] [Abstract][Full Text] [Related]
15. Structural, kinetic, and mutational studies of the zinc ion environment in tetrameric cytidine deaminase.
Johansson E; Neuhard J; Willemoës M; Larsen S
Biochemistry; 2004 May; 43(20):6020-9. PubMed ID: 15147186
[TBL] [Abstract][Full Text] [Related]
16. Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples.
Giovannetti E; Laan AC; Vasile E; Tibaldi C; Nannizzi S; Ricciardi S; Falcone A; Danesi R; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):720-5. PubMed ID: 18600531
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure determination and dynamic studies of Mycobacterium tuberculosis Cytidine deaminase in complex with products.
Sánchez-Quitian ZA; Timmers LF; Caceres RA; Rehm JG; Thompson CE; Basso LA; de Azevedo WF; Santos DS
Arch Biochem Biophys; 2011 May; 509(1):108-15. PubMed ID: 21295009
[TBL] [Abstract][Full Text] [Related]
18. CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer.
Zauri M; Berridge G; Thézénas ML; Pugh KM; Goldin R; Kessler BM; Kriaucionis S
Nature; 2015 Aug; 524(7563):114-8. PubMed ID: 26200337
[TBL] [Abstract][Full Text] [Related]
19. High-resolution melting analysis of sequence variations in the cytidine deaminase gene (CDA) in patients with cancer treated with gemcitabine.
Raynal C; Ciccolini J; Mercier C; Boyer JC; Polge A; Lallemant B; Mouzat K; Lumbroso S; Brouillet JP; Evrard A
Ther Drug Monit; 2010 Feb; 32(1):53-60. PubMed ID: 20010457
[TBL] [Abstract][Full Text] [Related]
20. Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.
Lumeau A; Bery N; Francès A; Gayral M; Labrousse G; Ribeyre C; Lopez C; Nevot A; El Kaoutari A; Hanoun N; Sarot E; Perrier M; Pont F; Cerapio JP; Fournié JJ; Lopez F; Madrid-Mencia M; Pancaldi V; Pillaire MJ; Bergoglio V; Torrisani J; Dusetti N; Hoffmann JS; Buscail L; Lutzmann M; Cordelier P
Cancer Res; 2024 Apr; 84(7):1013-1028. PubMed ID: 38294491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
